Coverage Universe
Companies work with LifeSci Capital because of our distinct influence over investor engagement and behavior
Sort by Sector
Abivax
(ABVX.PA)
Analyst: Sam Slutsky
Immunology and inflammation
Adagene
(ADAG)
Analyst: Charles Zhu
Oncology
ALX Oncology
(ALXO)
Analyst: Sam Slutsky
Oncology
Amylyx
(AMLX)
Analyst: Rami Katkhuda
Rare disease
Aquestive Therapeutics
(AQST)
Analyst: Francois Brisebois
Immunology and inflammation
ArriVent
(AVBP)
Analyst: Sam Slutsky
Oncology
Aura Biosciences
(AURA)
Analyst: Oliver McCammon
Oncology
Candel
(CADL)
Analyst: Oliver McCammon
Oncology
Celcuity
(CELC)
Analyst: Oliver McCammon
Oncology
Celldex
(CLDX)
Analyst: Sam Slutsky
Immunology and inflammation
Centessa Pharmaceuticals
(CNTA)
Analyst: Francois Brisebois
CNS
CG Oncology
(CGON)
Analyst: Sam Slutsky
Oncology
Cogent
(COGT)
Analyst: Sam Slutsky
Oncology
Compass Pathways
(CMPS)
Analyst: Francois Brisebois
CNS
Compass Therapeutics
(CMPX)
Analyst: Charles Zhu
Oncology
Context Therapeutics
(CNTX)
Analyst: Charles Zhu
Oncology
Corbus
(CRBP)
Analyst: Oliver McCammon
Oncology
Crescent BioPharma
(CBIO)
Analyst: Charles Zhu
Oncology
Crinetics Pharmaceuticals
(CRNX)
Analyst: Kate Dellorusso
Endocrinology
Damora
(DMRA)
Analyst: Sam Slutsky
Hematology
DBV Technologies
(DBVT)
Analyst: Sam Slutsky
Immunology and inflammation
Definium
(DFTX)
Analyst: Francois Brisebois
CNS
Dianthus Therapeutics
(DNTH)
Analyst: Rami Katkhuda
Immunology and inflammation
Disc Medicine
(IRON)
Analyst: Rami Kathkhuda
Hematology
Dyne
(DYN)
Analyst: Francois Brisebois
Rare disease
Eledon
(ELDN)
Analyst: Rami Katkhuda
Immunology and inflammation
Enliven Therapeutics
(ELVN)
Analyst: Sam Slutsky
Oncology
Eupraxia
(EPRX)
Analyst: Sam Slutsky
Immunology and inflammation
iBio
(IBIO)
Analyst: Patrick Dolezal
Cardiometabolic
Ideaya Biosciences
(IDYA)
Analyst: Charles Zhu
Oncology
Immunome
(IMNM)
Analyst: Charles Zhu
Oncology
Immunovant
(IMVT)
Analyst: Sam Slutsky
Immunology and inflammation
InflaRx
(IFRX)
Analyst: Sam Slutsky
Immunology and inflammation
Inhibikase
(IKT)
Analyst: Gaurav Maini
Rare disease
Inhibrx Biosciences
(INBX)
Analyst: Oliver McCammon
Oncology
Inventiva
(IVA)
Analyst: Rami Katkhuda
Immunology and inflammation
Jade Biosciences
(JBIO)
Analyst: Rami Katkhuda
Nephrology
Janux
(JANX)
Analyst: Oliver McCammon
Oncology
Kodiak
(KOD)
Analyst: Patrick Dolezal
Ophthalmology
Kura Oncology
(KURA)
Analyst: Charles Zhu
Oncology
Larimar
(LRMR)
Analyst: Francois Brisebois
Rare disease
Liquidia
(LQDA)
Analyst: Gaurav Maini
Rare disease
Maze Therapeutics
(MAZE)
Analyst: Rami Katkhuda
Nephrology
MBX Biosciences
(MBX)
Analyst: Patrick Dolezal
Endocrinology
Mereo
(MREO)
Analyst: Kate Dellorusso
Rare disease
Mineralys Therapeutics
(MLYS)
Analyst: Rami Katkhuda
Cardiometabolic
Molecular Partners
(MOLN)
Analyst: Charles Zhu
Oncology
Monte Rosa Therapeutics
(GLUE)
Analyst: Oliver McCammon
Immunology and inflammation
Moonlake Immunotherapeutics
(MLTX)
Analyst: Rami Kathkhuda
Immunology and inflammation
Neurogene
(NGNE)
Analyst: Patrick Dolezal
Rare disease
Nuvalent
(NUVL)
Analyst: Charles Zhu
Oncology
Oculis
(OCS)
Analyst: Patrick Dolezal
Ophthalmology
Olema
(OLMA)
Analyst: Sam Slutsky
Oncology
OnKure
(OKUR)
Analyst: Sam Slutsky
Oncology
Opus Genetics
(IRD)
Analyst: Francois Brisebois
Ophthalmology
Oruka Therapeutics
(ORKA)
Analyst: Sam Slutsky
Immunology and inflammation
Ovid
(OVID)
Analyst: Francois Brisebois
CNS
Palvella Therapeutics
(PVLA)
Analyst: Sam Slutsky
Rare disease
Perspective Therapeutics
(CATX)
Analyst: Oliver McCammon
Oncology
Praxis Precision Medicines
(PRAX)
Analyst: Francois Brisebois
CNS
Prime
(PRME)
Analyst: Thibaut R. Pardo-Garcia
Genetic medicines
Protara
(TARA)
Analyst: Charles Zhu
Oncology
Pyxis Oncology
(PYXS)
Analyst: Sam Slutsky
Oncology
Revolution Medicines
(RVMD)
Analyst: Charles Zhu
Oncology
Rocket Pharmaceuticals
(RCKT)
Analyst: Patrick Dolezal
Genetic medicines
Savara
(SVRA)
Analyst: Francois Brisebois
Rare disease
Sionna
(SION)
Analyst: Gaurav Maini
Rare disease
Soleno
(SLNO)
Analyst: Kate Dellorusso
Rare disease
Spyre Therapeutics
(SYRE)
Analyst: Sam Slutsky
Immunology and inflammation
Structure Therapeutics
(GPCR)
Analyst: Patrick Dolezal
Cardiometabolic
Surrozen
(SRZN)
Analyst: Patrick Dolezal
Ophthalmology
Tarsus
(TARS)
Analyst: Francois Brisebois
Ophthalmology
Tectonic
(TECX)
Analyst: Gaurav Maini
Cardiopulmonary
Tenax
(TENX)
Analyst: Gaurav Maini
Cardiopulmonary
Tenaya Therapeutics
(TNYA)
Analyst: Thibaut R. Pardo-Garcia
Genetic medicines
TScan Therapeutics
(TCRX)
Analyst: Sam Slutsky
Oncology
Upstream Bio
(UPB)
Analyst: Kate Dellorusso
Immunology and inflammation
Vera Therapeutics
(VERA)
Analyst: Rami Katkhuda
Nephrology
Viridian Therapeutics
(VRDN)
Analyst: Rami Katkhuda
Immunology and inflammation
VYNE Therapeutics
(VYNE)
Analyst: Rami Katkhuda
Immunology and inflammation
Zymeworks
(ZYME)
Analyst: Charles Zhu